A股異動 | 無視風險提示 北大醫藥(000788.SZ)六連板
格隆匯3月16日丨北大醫藥(000788.SZ)連續第六個交易日漲停,現報13.2元,封單不足一萬手,暫成交20億元,最新市值78億元,換手率達28%。

北大醫藥昨日晚間發佈股票交易異常波動公吿,近日,公司注意到網絡上存在有關公司與日本鹽野義合作開發新冠特效藥的傳聞。在此鄭重申明:公司從未開展過新冠特效藥的研發,也未曾與日本鹽野義商談過有關新冠特效藥的合作事宜。敬請各位投資者切勿相信網絡傳聞,關注投資風險,理性投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.